X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES BIOCON JUBILANT LIFE SCIENCES/
BIOCON
 
P/E (TTM) x 13.3 18.1 73.4% View Chart
P/BV x 1.9 2.9 65.6% View Chart
Dividend Yield % 0.6 0.4 153.8%  

Financials

 JUBILANT LIFE SCIENCES   BIOCON
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-18
BIOCON
Mar-18
JUBILANT LIFE SCIENCES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,0391,188 87.5%   
Low Rs600305 196.7%   
Sales per share (Unadj.) Rs482.668.7 702.2%  
Earnings per share (Unadj.) Rs40.77.6 539.3%  
Cash flow per share (Unadj.) Rs67.414.0 482.2%  
Dividends per share (Unadj.) Rs3.001.00 300.0%  
Dividend yield (eoy) %0.40.1 273.3%  
Book value per share (Unadj.) Rs262.386.3 303.8%  
Shares outstanding (eoy) m155.79600.00 26.0%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x1.710.9 15.6%   
Avg P/E ratio x20.198.9 20.4%  
P/CF ratio (eoy) x12.253.4 22.8%  
Price / Book Value ratio x3.18.6 36.1%  
Dividend payout %7.413.2 55.6%   
Avg Mkt Cap Rs m127,670447,900 28.5%   
No. of employees `0002.46.1 39.6%   
Total wages/salary Rs m15,5599,311 167.1%   
Avg. sales/employee Rs Th30,861.46,705.8 460.2%   
Avg. wages/employee Rs Th6,387.01,514.2 421.8%   
Avg. net profit/employee Rs Th2,604.4736.9 353.4%   
INCOME DATA
Net Sales Rs m75,17841,234 182.3%  
Other income Rs m4002,062 19.4%   
Total revenues Rs m75,57943,296 174.6%   
Gross profit Rs m15,1848,291 183.1%  
Depreciation Rs m4,1513,851 107.8%   
Interest Rs m2,843615 462.2%   
Profit before tax Rs m8,5915,887 145.9%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2471,569 143.2%   
Profit after tax Rs m6,3444,531 140.0%  
Gross profit margin %20.220.1 100.4%  
Effective tax rate %26.226.7 98.1%   
Net profit margin %8.411.0 76.8%  
BALANCE SHEET DATA
Current assets Rs m31,89841,486 76.9%   
Current liabilities Rs m20,04721,413 93.6%   
Net working cap to sales %15.848.7 32.4%  
Current ratio x1.61.9 82.1%  
Inventory Days Days6864 105.6%  
Debtors Days Days5594 58.3%  
Net fixed assets Rs m60,71550,661 119.8%   
Share capital Rs m1563,000 5.2%   
"Free" reserves Rs m40,71048,808 83.4%   
Net worth Rs m40,86551,808 78.9%   
Long term debt Rs m30,47817,898 170.3%   
Total assets Rs m96,17699,897 96.3%  
Interest coverage x4.010.6 38.0%   
Debt to equity ratio x0.70.3 215.9%  
Sales to assets ratio x0.80.4 189.4%   
Return on assets %9.65.2 185.4%  
Return on equity %15.58.7 177.5%  
Return on capital %16.09.6 166.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,40212,058 119.4%   
Fx outflow Rs m12,0447,348 163.9%   
Net fx Rs m2,3584,710 50.1%   
CASH FLOW
From Operations Rs m13,0326,621 196.8%  
From Investments Rs m-6,177-6,840 90.3%  
From Financial Activity Rs m-9,011-2,397 375.9%  
Net Cashflow Rs m-2,123-2,612 81.3%  

Share Holding

Indian Promoters % 45.6 40.4 112.9%  
Foreign collaborators % 3.5 20.6 17.0%  
Indian inst/Mut Fund % 8.7 8.4 103.6%  
FIIs % 21.2 10.7 198.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 19.9 106.0%  
Shareholders   23,815 109,995 21.7%  
Pledged promoter(s) holding % 15.9 0.0 39,625.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Power and Energy Stocks Witness Buying(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the power sector.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 25, 2019 03:06 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS